United States

Back to map

Showing 81-90 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Targeting pathogenic Th17 cells as shared mechanisms in MS, SLE and T1D Icahn School of Medicine at Mount Sinai Ka Lung Cheung Cures 01-September-2026 to 31-August-2027 $149,950.03
Exploring the Effects of Beta Cell Regenerative Drugs on Cell Fate Decisions in Human Pancreatic Islets Icahn School of Medicine at Mount Sinai Esra Karakose Cures 01-March-2025 to 28-February-2030 $999,999.00
Bringing Beta Cell Regenerative Therapy to the Clinic Icahn School of Medicine at Mount Sinai Andrew Stewart Cures 01-January-2024 to 31-December-2026 $1,000,000.00
A multiorgan autoimmune T-cell killing in-vitro platform to improve T1D drug screening Indiana Biosciences Research Institute Roberto Mallone Cures 01-June-2026 to 31-May-2027 $196,040.47
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D Indiana Biosciences Research Institute Michael Kalwat Cures 01-December-2024 to 30-November-2027 $748,169.00
Clinical Translation of T-1123, an Ultra-rapid, Concentrated, Temperature stable Novel Insulin Analog Invictus Therapeutics, LLC Robyn Day Improving Lives 15-October-2025 to 31-May-2027 $1,437,112.00
Adult T1D Detection at Geisinger IQVIA, Inc. Nadejda Leavitt Cures 01-July-2023 to 30-June-2027 $1,033,123.00
Advancing T1D Detection and Care Through AI IQVIA, Inc. Nadejda Leavitt Cures 01-February-2025 to 31-October-2026 $345,083.00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850,000.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01